April 01, 2026
April 01, 2026
FDA Broadens CFTR Therapy Eligibility
April 01, 2026
Case Report Shows Carbimazole's ‘Triple-Hit’
April 01, 2026
Inside Access, Outside the Rules
April 01, 2026
Evolocumab Reduced CV Events in Diabetes
April 01, 2026
Tirzepatide Linked to Lower Cardiorenal Events
Latest Headlines
View More
April 01, 2026
FDA Approves Lilly’s Foundayo Oral GLP-1 Pill
April 01, 2026
FDA Broadens CFTR Therapy Eligibility
April 01, 2026
Case Report Shows Carbimazole's ‘Triple-Hit’
April 01, 2026
Inside Access, Outside the Rules
April 01, 2026
Evolocumab Reduced CV Events in Diabetes
April 01, 2026
Tirzepatide Linked to Lower Cardiorenal Events
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Trending Now
1
Floaters May Signal Higher Risk Than Flashes
2
New ACA Rules Target Fraud, Raise Concerns
3
Top 10 States for Retiring Physicians: Where Part-Time Practice, Licensing Flexibility, and Lifestyle Align
4
Burnout Tied to Physician Turnover
5
Physician Disability, Exit Risk Rise
6
Exercise in a Pill Is Now in Human Trials
Conference Coverage
American College of Cardiology's 75th Annual Scientific Session & Expo
April 01, 2026
Evolocumab Reduced CV Events in Diabetes
April 01, 2026
Tirzepatide Linked to Lower Cardiorenal Events
March 31, 2026
Sudden Death Trajectories in HFpEF, HFmrEF
AAO-HNSF 2025 Annual Meeting & OTO EXPO
March 27, 2026
Opioid Prescribing Trends After Guidelines
2026 AAN Annual Meeting
March 09, 2026
Newborn Vitamin K Refusal Trends
March 03, 2026
GLP-1 RAs in Chronic Migraine
Clinical Guidelines
View More
April 01, 2026
Evolocumab Reduced CV Events in Diabetes
Commentary & Perspectives
View More
March 26, 2026
Obesity’s Cancer Role Underestimated
March 26, 2026
Limits of Negative Infection Studies in AD
March 23, 2026
Influencer Drug Promotion Raises Concerns
FDA & Government News
View More
April 01, 2026
FDA Approves Lilly’s Foundayo Oral GLP-1 Pill
April 01, 2026
FDA Broadens CFTR Therapy Eligibility
April 01, 2026
Inside Access, Outside the Rules
March 31, 2026
FDA Monthly Preview: Key April Decisions to Watch
Business Management
View More
